Clinical Trial Update: Using Glucose Sensors to Prevent Hypoglycemia [Phase 3]

View source ↗

Summary

A Phase 3 trial update describes using glucose-sensor technology to prevent hypoglycemia in people with Type 1 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Alberta | Conditions: Type 1 Diabetes, Hypoglycemia | Phase 3 | Status: COMPLETED